Beata Morak-Młodawska
Has grant
Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Professor Beata Morak-Młodawska is a faculty member at the Medical University of Silesia, Poland. Her research focuses on anticancer agents, specifically the design and synthesis of novel compounds with therapeutic potential. Recent works include studies on the lipophilicity and pharmacokinetic properties of aza-phenothiazines and hybrid molecules for cytotoxic and immunomodulatory activities. She is also involved in investigations of antioxidant and anti-glycation effects of various compounds.
Recent Grants
Grant: Close
The Medal of National Education
Open Date: 2021-01-01
Close Date: 2021-01-01
Grant: Close
Individual award of the Minister of Health for habilitation thesis
Open Date: 2018-01-01
Close Date: 2018-01-01
Grant: Close
Scientific scholarship of the Minister of National Education
Open Date: 1998-01-01
Close Date: 1999-01-01
Grant: Close
The Medal "Omnium Studiosorum Optimo"
Open Date:
Close Date:
Articles (26)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Lipophilicity is one of the most important properties of compounds required to estimate the absorption, distribution, and transport in biological systems, in addition to solubility, stability, and acid–base nature. It is crucial in predicting the ADME profile of bioactive compounds. The study assessed the usefulness of computational and chromatographic methods (thin-layer chromatography in a reversed-phase system, RP-TLC) for estimating the lipophilicity of 21 newly synthesized compounds belonging to diquinothiazines and quinonaphthiazines. In order to obtain reliable values of the relative lipophilicities of diquinothiazines and quinonaphthiazines, the partition coefficients obtained using different algorithms such as AlogPs, AClogP, AlogP, MLOGP, XLOGP2, XLOGP3, logP, and ClogP were compared with the chromatographic RM0 values of all the tested compounds measured by the experimental RP-TLC method (logPTLC). Additionally, logPTLC values were also correlated with other descriptors, as well as the predicted ADME and drug safety profiling parameters. The linear correlations of logPTLC values of the tested compounds with other calculated molecular descriptors such as molar refractivity, as well as ADME parameters (Caco-2 substrates, P-gp inhibitors, CYP2C19, and CYP3A4) generally show poor predictive power. Therefore, in silico ADME profiling can only be helpful at the initial step of designing these new candidates for drugs. The compliance of all discussed diquinothiazines and naphthoquinothiazines with the rules of Lipiński, Veber, and Egan suggests that the tested pentacyclic phenothiazine analogs have a chance to become therapeutic drugs, especially orally active drugs.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Collaborators (13)
Aleksandra Owczarzy
Medical University of Silesia
Marta Karkoszka
Medical University of Silesia
Małgorzata Dołowy
Medical University of Silesia
Małgorzata Jeleń
Medical University of Silesia
Anna Kasprzycka
assistant professor
Silesian University of Technology
Małgorzata Maciążek-Jurczyk
Assistant of Professor
Medical University of Silesia
Zuzanna Rzepka
Medical University of Silesia
Adam Konefał
University of Silesia
Dorota Wrześniok
Professor
Medical University of Silesia
Magdalena Skonieczna
Silesian University of Technology
Rafal Korlacki
University of Nebraska - Lincoln
Karolina Kulig
Medical University of Silesia
Wojciech Rogóż
Medical University of Silesia
Make your next move.
Prepare your application
Review drafts before you send them.